AFFECTIVE DISORDERS IN INTELLECTUAL DISABILITIES DIAGNOSTIC PITTFALLS AND PHARMACOLOGICAL TREATMENT STRATEGIES - PowerPoint PPT Presentation

1 / 30
About This Presentation
Title:

AFFECTIVE DISORDERS IN INTELLECTUAL DISABILITIES DIAGNOSTIC PITTFALLS AND PHARMACOLOGICAL TREATMENT STRATEGIES

Description:

AFFECTIVE DISORDERS IN INTELLECTUAL DISABILITIES DIAGNOSTIC PITTFALLS AND PHARMACOLOGICAL TREATMENT STRATEGIES Mental Health in Intellectual Disabilities (formerly ... – PowerPoint PPT presentation

Number of Views:112
Avg rating:3.0/5.0

less

Transcript and Presenter's Notes

Title: AFFECTIVE DISORDERS IN INTELLECTUAL DISABILITIES DIAGNOSTIC PITTFALLS AND PHARMACOLOGICAL TREATMENT STRATEGIES


1
AFFECTIVE DISORDERS IN INTELLECTUAL
DISABILITIESDIAGNOSTIC PITTFALLS AND
PHARMACOLOGICAL TREATMENT STRATEGIES
  • Mental Health in Intellectual Disabilities
    (formerly MHMR), Antwerp, May 31th 2007
  • Prof.Dr. Willem M.A. Verhoeven
  • Vincent van Gogh Institute for Psychiatry,
    NL-Venray

2
Prevalence of affective spectrum disorders
  • (Bipolar)Affective Anxiety OCD
  • Lund, 1985 1.7 2.0 -
  • Acta Psychiatr Scand
  • Corbett, 1979 4.0 25.4 -
  • In Psychiatric Illness
  • and Mental Handicap
  • Cooper Bailey, 2001 6.0 7.2 2.5
  • Ir J Psychol Med
  • Holden Gitlesen, 2004 11 25 9
  • J Intellect Disabil Res
  • Cooper et al., 2007 6.6 3.8 0.7
  • Br J Psychiatry

3
DIMENSIONAL DIAGNOSTIC PROCEDURES AND
FUNCTIONAL PHARMACOTHERAPY OF AFFECTIVE DISORDERS
IN INTELLECTUAL DISABILITIES 
  • diagnostic procedures
  • manifestations of depression
  • unstable mood disorder
  • behavioural phenotypes and depression
  • pharmacotherapeutic strategies

4
DIAGNOSTIC INSTRUMENTS
  • ICD-10 Guide for Mental Retardation
  • DSM-IV
  • ICD-10
  • Diagnostic Criteria for psychiatric disorders for
    use with adults with Learning Disabilities/Mental
    Retardation (DC-LD)
  • Clinical Diagnosis

5
DIAGNOSTIC PROCEDURES
  • REFERENCE COMPLAINT
  • ?
  • VIDEO REGISTRATION CONSENSUS MEETING
  • ?
  • SPECIFICATION OF SYMPTOMATOLOGY
  • ?
  • QUESTIONS
  • genetic etiology
  • neurological examination
  • epilepsy
  • somatic examination
  • course
  • hereditary factors
  • plasma concentrations psychotropics and
    anticonvulsants
  • delirious state
  • environmental variables
  • results previous interventions
  • attenuation of treatment effects
  • tar dive behavioural effects of psychotropics and
    anticonvulsants

6
BEHAVIOURS, SIGNS AND SYMPTOMS OF DEPRESSION
  • Level of intellectual disability (number of
    subjects)
  •  Diagnosis Severe/profound (n15) Mild/moderate
    (n7)
  •  
  • Depressed affect 15 6
  • Sleep disturbance (insomnia 13 hypersomnia
    1) 14 5
  • Appetite disturbance (decrease 12 increase
    1) 13 3
  • Loss of interest 12 0
  • Social isolation 11 0
  • Self-injurious behaviour 10 5
  • Psychomotor agitation 10 6
  • Aggression 9 2
  • Irritability 7 2
  • Lack of emotional response 6 4
  • Screaming 6 0
  • Stereotypical behaviour 6 0
  • Psychomotor retardation 5 3
  • Weight loss 6 0
  • Anxiety 5 6
  • Constipation 5 0

7
SYMPTOMS OF DEPRESSION IN INTELLECTUAL
DISABILITIES 
  • MORE THAN 50 LESS THAN 50
  • irritability somatic complaints
  • depressed affect lack of emotional response
  • tearfulness diurnal variation
  • loss of interest psychomotor retardation
  • sleep disturbance loss of appetite
  • psychomotor agitation weight loss
  • self-injurious behaviour suicidal ideation
  • loss of energy obsessive-compulsive behaviour
  • constipation euphoria
  • anxiety labile mood
  • aggression screaming
  • social isolation stereotyped behaviour
  • antisocial behaviour vomiting
  • decreased concentration incontinence
  • anhedonia guilt feelings
  • increased speech change in sexual activities
  • decreased appetite hallucinations
  • withdrawn behaviour delusions

8
FUNCTIONAL DOMAINS OF DEPRESSIVE DISORDER (n58)
  • Domains mild/moderate (n47) severe/profound
    (n11)
  • n n
  • Affect
  • Depressed affect 36 77 4 36
  • Labile mood 22 47 8 73
  • Dysphoria 20 43 4 36
  • Tearfullness 22 47 6 55
  • Anxieties 28 60 7 64
  • Motivation
  • Loss of energy 31 66 3 27
  • Loss of interest 27 57 2 18
  • Anhedonia 7 15 0 0
  • Withdrwan behaviour 27 57 6 55
  • Motor
  • Psychomotor retardation 6 13 2 18
  • Psychomotor agitation 26 55 9 82
  • Stereotyped behaviour 17 36 9 82
  • Irritability 28 60 10 91
  • Screaming 22 47 6 55

9
SYMPTOMS (PRESENCE 50) OF AFFECTIVE SPECTRUM
DISORDERS IN INTELLECTUAL DISABILITIES (n285)
  • depression affective spectrum
  • (n58) (n136)
  • psychomotor agitation
  • stereotypies -
  • aggression -
  • self-injuries -
  • anxieties
  • irritability
  • depressed mood -
  • mood swings
  • dysphoria -
  • loss of energy -
  • loss of interest -
  • withdrawn behaviour -
  • difficult to handle
  •  
  • depression, anxiety disorder, bipolar disorder
    and unstable mood disorder
  • Verhoeven et al., The European Journal of
    Psychiatry, 1849-53, 2004

10
UNSTABLE MOOD DISORDER
  • Sollier (1901)
  • "on voit des changements brusques dhumeur que
    rien ne paraît motiver,
  • des actes bizarres et des mouvements capricieux"
  •  
  • Duncan (1936)
  • considerable degree of emotional instability
    that could not be considered as typical for
    bipolar affective disorder
  •  
  • Verhoeven Tuinier (1997)
  • high prevalence of atypical bipolar and mood
    disorders with features like inactivity, lability
    and irritability ? unstable mood disorder,
    characterized by an episodic pattern of disturbed
    mood, anxiety and behaviour

11
UNSTABLE MOOD DISORDER IN INTELLECTUAL
DISABILITIES
  • affective instability 
  • episodic motor inhibition or disinhibition
  • irritability 
  • rapid mood changes 
  • unprovoked crying 
  • sleep disturbances
  • Adapted from Matson et al., 1991 Einfeld
    Aman, 1995 Meins, 1994

12
DISORDERED STRESS FEEDBACK IN INTELLECTUAL
DISABILITIES
  • increased arousability 
  • anxiousness 
  • stereotyped behaviour 
  • avoidant behaviour 
  • irritability
  • Adapted from Einfeld Aman, 1995

13
FUNCTIONAL DOMAINS OF UNSTABLE MOOD DISORDER
(n64)
  • Domains Presence Percentage
  • mood
  • rapide mood swings 22 34
  • mood swings 41 64
  • episodic dysphoria 37 56
  • anxiety
  • anxieties 35 55
  • irritability 35 55
  • motor
  • disorganized behaviour 17 27
  • hyperactivity 39 61
  • stereotypies 36 56
  • self-injuries 25 39
  • impulsivity 25 39
  • aggression 35 55
  •  
  • Verhoeven et al., 2001, 2004

14
UNSTABLE MOOD DISORDER (n28)
  • METHODS - 1
  • subjects
  • - 18 male, 10 female
  • - mean age 37.3 year
  • - mild to severe intellectual disabilities
  • etiology
  • - unknown 18
  • - perinatal complications 6
  • - encephalitis postvaccinalis 1
  • - specific syndromes 6
  • diagnosis
  • - rapid or episodic fluctuations in behaviour
  • - prominent mood deviations mostly with motor
    signs like self-injuries and aggression
  • Verhoeven Tuinier, JARID, 14147-154, 2001

15
UNSTABLE MOOD DISORDER (n28)
  • METHODS - 2
  •   
  • previous psychiatric diagnoses
  • - mood disorder 12
  • - (atypical) autism 4
  • - psychotic disorder 3
  • - panic disorder 1
  • current medication
  • - anticonvulsants for epilepsy 3
  • - anticonvulsants for behaviour control 2
  • - antipsychotics 20
  • - antidepressants 6
  • - anxiolytics 8
  • Verhoeven Tuinier, 2001

16
UNSTABLE MOOD DISORDER (n28)
  • METHODS - 3
  •  
  • treatment
  • - valproic acid, starting at a daily dose of 300
    mg
  • - dosage adjustment over 6 weeks according to
  • plasma concentration or clinical effect
  • - concomitant medication unchanged 3 months prior
    and during the first 12 weeks of treatment
  •  
  • Verhoeven Tuinier, 2001

17
CYCLOTHYMIA AND UNSTABLE MOOD DISORDER
  • cyclothymia
  • - persistent instability of mood, involving
    numerous periods
  • of mild depression and mild elation
  • - mood swings not related to life events
  •  
  • unstable mood disorder
  • - long-lasting episodic disturbances in the mood,
  • anxiety and motor domains
  •  
  • main difference
  • - presence of elation in cyclothymia

18
CONCLUSIONS UNSTABLE MOOD DISORDER
  • often described as (atypical) bipolar disorder
    without, however, familial load  
  • the here advocated unstable mood disorder
    resembles the description of the ICD-10 diagnosis
    cyclothymia but lacks episodes of elation 
  • treatment effects of valproic acid at a mean
    daily dose level and mean plasma concentration of
    1343 mg and 63 mg/l respectively
  • clinically relevant and sustained improvement
    both in terms of behaviour stability and symptom
    reduction in 68 of the subjects

19
RAPID CYCLING BIPOLAR AFFECTIVE DISORDER
  • characteristics
  • - symptomatology characterized by observable
    behaviours rather than by reports of subjective
    mood states
  • - mostly family history with affective disorder
  • - first episode affective disorder at or before
    age of 17
  • - gender differences not present
  • - not associated with particular organic
    pathology
  •  
  • treatment
  • - mood stabilizers, preferably sodium valproate
  •  
  • From JIDR, 43, 349-359, 1999

20
EXAMPLES OF BEHAVIOURAL PHENOTYPESASSOCIATED
WITH AFFECTIVE DISORDERS
  • VELO-CARDIO-FACIAL-SYNDROME (chromosome 22)
  • - affective spectrum disorders
  •  
  • KLINEFELTER SYNDROME (47XXY)
  • - bipolar affective disorders
  •  
  • PRADER-WILLI SYNDROME (chromosome 15)
  • - bipolar (affective) disorders
  •  
  • WOLFRAM SYNDROME CARRIERS (chromosome 4)
  • - affective disorders
  • - suicidal ideation
  •  
  • FRAGILE-X SYNDROME CARRIERS (X-chromosome)
  • - affective/anxiety disorders
  •  
  • DOWN SYNDROME (trisomy-21)
  • - affective disorders

21
EXAMPLES OF BEHAVIOURAL PHENOTYPES ASSOCIATED
WITH AFFECTIVE DISORDERS
  • DOWN SYNDROME (trisomy-21)
  • atypical depression social withdrawal
  • reduced energy
  • irritability
  • psychomotor retardation
  • regression of self-care
  • hypochondriasis
  • aggression
  • sleep disturbances
  • reduced speech
  • auditory hallucinations
  •  
  • From Myers Pueschel, 1995

22
PATIENTS WITH DOWN SYNDROME REFERRED FOR
DEPRESSION (n20)
  • domains presence percentage
  • motor
  • disorganized behaviour 3 15
  • obsessive-compulsive rituals 6 30
  • stereotypies 8 40
  • psychomotor-agitation 7 35
  • psychomotor retardation 5 25
  • impulsivity 7 35
  • aggression 9 45
  • self-injuries 9 45
  • temper tantrums 5 25
  • difficult to handle 5 25
  • psychotic features
  • confusion 3 15
  • visual hallucinations 2 10
  • auditory hallucinations 3 15
  • delusional ideas 1 5
  • paranoid ideation 2 10
  •  

23
PATIENTS WITH DOWN SYNDROME REFERRED FOR
DEPRESSION (n20)
  • psychiatric diagnoses
  •  
  • major depression 8
  • unstable mood disorder 5
  • self- injurious behaviour 1
  • hypothyroidism 2
  • obsessive compulsive disorder 1
  • anxiety disorder 1
  • Gilles de la Tourette 1
  • no disorder 1
  •  
  • Verhoeven Tuinier, 2002

24
FUNCTIONAL DOMAINS OF DEPRESSIVE DISORDER IN
PATIENTS TREATED WITH CITALOPRAM (N20)Verhoeven
et al. European Psychiatry, 16104-108, 2001
  • domains presence percentage
  • Affect
  • Depressed affect 7 35
  • Labile mood 4 20
  • Dysphoria 7 35
  • Tearfulness 3 15
  • Anxieties 9 45
  • Motivation
  • Loss of energy 7 35
  • Loss of interest 3 15
  • Anhedonia 1 5
  • Withdrawn behavior 9 45
  • Motor
  • Psychomotor retardation 2 10
  • Psychomotor agitation 7 35
  • Stereotyped behaviour 7 35
  • Irritability 9 45
  • Screaming 1 5
  • Aggression 7 35

25
CITALOPRAM IN DEPRESSION Methods 1 Verhoeven
et al. European Psychiatry, 16104-108, 2001
  • Subjects 10 male, 10 female
  • mild to severe ID
  • mean age 36,9 years
  • Etiology unknown 11
  • perinatal complications 4
  • (meningo)-encephalitis 2
  • rhesus antagonism 1
  • specific syndromes 2

26
CITALOPRAM IN DEPRESSION Methods 2
  • Previous (psychiatric) diagnoses
  • mood disorder 4
  • (atypical) autism 2
  • pychotic disorder 1
  • history of epilepsy 4
  • congenital cataract 2
  • Current medication
  • anticonvulsants 12
  • antipsychotics 11
  • anxiolytics 3

27
CITALOPRAM IN DEPRESSION Methods 3
  • Treatment
  • -citalopram, starting at 20mg daily and kept
    stable during first 6 weeks
  • -dose adjustment according to clinical
    response up to 60mg daily maximally
  • -follow-up period 6 (n11) to 12 (n9) months
  • -measurement of plasmaconcentrations of
    anticonvulsants, citalopram and desmethyl-
    citalopram

28
RESULTS AND CONCLUSIONS CITALOPRAM Verhoeven et
al. European Psychiatry, 16104-108, 2001
  • Results
  • -Daily dose range 20-60mg mean 33mg
  • -Plasmaconcentrations 30-105 respectively
    19-75µgr/l
  • -Side effects seizure n1 delirious state n1
  • -Marked improvement in 12 out of 20 patients
  • -No relapse during long term treatment over gt12
    months
  • -No pharmacokinetic drug-drug interactions
  • Conclusion
  • -Well tolerated, safe and effective
  • -Optimal dose 20-30mg daily

29
RESULTS OF TREATMENT WITH SSRIS IN INTELLECTUAL
DISABILITIES
  • -Studies case reports only
  • -Compounds fluoxetine (19), sertraline (7),
    paroxetine (5),
  • citalopram(1), fluvoxamine (1)
  • -Indications depressive and obsessive-compulsive
    disorders, maladaptive behaviours
  • -Conclusions results questionable because of
    publication bias
  • sometimes deterio ration of behaviour
  • anxiety as target symptom virtually absent
  • -Note over 15 years tenfold increase of
    prescription of SSRIs
  • Verhoeven Tuinier, 2005 In Trends in
    Serotonin Uptake Inhibitor Research
  • Nova Science Publishers, Inc, New York.

30
CONCLUSIONS
  • increased vulnerability for stress-related
    disorders in ID
  •  
  • categorical diagnostic systems, particularly
    DSM-IV, are not appropriate in ID
  •  
  • dimensional diagnostic approach is necessary
    for delineation of atypical manifestations of
    affective disorders, unstable mood disorder and
    psychopathological phenotypes
  • symptom profile and course of disease (rapid
    cycling!) determine choice of pharmacological
    strategy antidepressant and/or mood stabilizer
  • compounds of first choice antidepressants
    citalopram, nortriptyline mood stabilizers
    valproic acid, lithium
Write a Comment
User Comments (0)
About PowerShow.com